D Molecular Therapeutics, Inc. ( (FDMT) ) has released its Q3 earnings. Here is a breakdown of the information 4D Molecular Therapeutics, Inc.
High-cost markets see renewed leases, while some push for premium office spaces. Leasing volumes across the Asia-Pacific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback